LMS Medical Sees Fiscal 2008 Revenue Jump 72% Over F07 - Q4/F08 Revenue Hits New Record
May 14 2008 - 1:35PM
PR Newswire (US)
MONTREAL, May 14 /PRNewswire-FirstCall/ -- LMS Medical Systems
(TSX: LMZ,) a healthcare technology company and developer of the
CALM(R) patient safety software system for obstetrics, today
reported preliminary results for Fiscal 2008 (March 31), which saw
a substantial rise in revenues over the previous fiscal year. All
amounts are in Canadian dollars and are unaudited. Revenue
continues to grow substantially year over year. For F08, revenue
totaled $4.92 million compared to $2.86 million in F07 and $1.58
million in F06. Fourth quarter revenue totaled $2.28 million, a 59%
increase compared to $1.43 million in the fourth quarter of F07.
Fourth quarter revenue in F06 totaled $.3 million. Also, as a
significant percentage of the company's revenues come from the
United States, the strength of the Canadian dollar impacted
results. At a constant rate of exchange as of the beginning of the
fiscal year, revenue would have increased by an additional 12%.
Complete audited results for the fiscal year ended March 31, 2008
and Management's Discussion and Analysis will be released on or
about June 13, 2008. About LMS: LMS is a leader in the application
of advanced mathematical modeling and neural networks for medical
use. The LMS CALM Suite provides physicians, nursing staff, risk
managers and hospital administrators with clinical information
systems and risk management tools designed to improve outcomes and
patient care for mothers and their infants during childbirth.
Except for historical information contained herein, the matters
discussed in this news release are forward-looking statements.
Because these forward-looking statements involve risks and
uncertainties, there are important factors that could cause actual
results to differ materially from those expressed implied by the
forward-looking statements including, but without limitation,
economic conditions in general and in the healthcare market, the
demand for and market for our products in domestic and
international markets, our current dependence on the CALM product
suite, the challenges associated with developing new products and
obtaining regulatory approvals if necessary, research and
development activities, the uncertainty of acceptance of our
products by the medical community, the lengthy sales cycle for our
products, third party reimbursement, competition in our markets,
including the potential introduction of competitive products by
others, our dependence on our distributors, physician training,
enforceability and the costs of enforcement of our patents,
potential infringements of our patents and the other factors set
forth from time to time in the Company's filings with the United
States Securities and Exchange Commission and with the Canadian
Securities Commissions. The Company has no intention of or
obligation to update or revise any forward-looking statements,
whether as a result of new information, future events or otherwise.
DATASOURCE: LMS MEDICAL SYSTEMS INC. CONTACT: about LMS Medical
Systems please contact: Andrea Miller, Communications, LMS Medical
Systems Inc., (514) 488-3461 Ext. 222, Fax: (514) 488-1880, ,
http://www.lmsmedical.com/; Grant Howard or Dave Burwell, The
Howard Group Inc., Toll Free: 1-888-221-0915, ,
http://www.howardgroupinc.com/
Copyright